Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Azin Alavi, Amene Ranjbar, Farzane Atighpoor & Shahram Zare. (2022) Comparison the efficacy of vaginal progesterone versus 17-alpha-hydroxyprogesterone caproate to prevent preterm birth in high-risk pregnant women undergo cerclage: a randomized clinical trial . The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 7438-7444.
Read now
Read now
Shruti Shambhavi, Rashmi Bagga, Pallavi Bansal, Jasvinder Kalra & Praveen Kumar. (2018) A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth. Journal of Obstetrics and Gynaecology 38:6, pages 800-806.
Read now
Read now
Articles from other publishers (16)
Nikhil Patil, Ronak Maheshwari & Sarika Wairkar. (2023) Advances in progesterone delivery systems: Still work in progress?. International Journal of Pharmaceutics 643, pages 123250.
Crossref
Crossref
Janneke van ’t Hooft, Charlotte E. van Dijk, Cathrine Axfors, Zarko Alfirevic, Martijn A. Oudijk, Khalid S. Khan, Ben W. J. Mol, Patrick M. Bossuyt & John P. A. Ioannidis. (2023) Assessing the usefulness of randomised trials in obstetrics and gynaecology. BJOG: An International Journal of Obstetrics & Gynaecology 130:7, pages 695-701.
Crossref
Crossref
Julie A. Talbert, Jacky Lu, Sabrina K. Spicer, Rebecca E. Moore, Steven D. Townsend & Jennifer A. Gaddy. (2022) Ameliorating adverse perinatal outcomes with Lactoferrin: An intriguing chemotherapeutic intervention. Bioorganic & Medicinal Chemistry 74, pages 117037.
Crossref
Crossref
Rupsa C. Boelig, Mariavittoria Locci, Gabriele Saccone, Elisabetta Gragnano & Vincenzo Berghella. (2022) Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM 4:5, pages 100658.
Crossref
Crossref
Ioannis Pavlidis & Sarah J. Stock. (2022) Preterm Birth Therapies to Target Inflammation. The Journal of Clinical Pharmacology 62:S1.
Crossref
Crossref
Hannah C. Zierden, Rachel L. Shapiro, Kevin DeLong, Davell M. Carter & Laura M. Ensign. (2021) Next generation strategies for preventing preterm birth. Advanced Drug Delivery Reviews 174, pages 190-209.
Crossref
Crossref
Lesley A Stewart, Mark Simmonds, Lelia Duley, Alexis Llewellyn, Sahar Sharif, Ruth AE Walker, Lucy Beresford, Kath Wright, Mona M Aboulghar, Zarko Alfirevic, Azam Azargoon, Rashmi Bagga, Elham Bahrami, Sean C Blackwell, Steve N Caritis, C Andrew Combs, Jennifer M Croswell, Caroline A Crowther, Anita F Das, Kay Dickersin, Kristina C Dietz, Andrew Elimian, William A Grobman, Alexander Hodkinson, Kimberley A Maurel, David S McKenna, Ben W Mol, Kelle Moley, Jamie Mueller, Anwar Nassar, Jane E Norman, John Norrie, John M O'Brien, Raphael Porcher, Shalini Rajaram, Line Rode, Dwight J Rouse, Carol Sakala, Ewoud Schuit, Marie-Victoire Senat, Sahar Sharif, Mark Simmonds, Joe L Simpson, Katherine Smith, Anne Tabor, Elizabeth A Thom, Melanie A van Os, Evelyn P Whitlock, Stephen Wood & Tom Walley. (2021) Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials. The Lancet 397:10280, pages 1183-1194.
Crossref
Crossref
Ananya Roy & Kakali Sinha Karmakar. (2019) Vaginal Micronized Progesterone and Intramuscular 17α OH Progesterone in Threatened Preterm Labour before 34 Weeks of Gestation. Journal of Evolution of Medical and Dental Sciences 8:50, pages 3796-3800.
Crossref
Crossref
A Jarde, O Lutsiv, J Beyene & SD McDonald. (2018) Vaginal progesterone, oral progesterone, 17‐OHPC, cerclage, and pessary for preventing preterm birth in at‐risk singleton pregnancies: an updated systematic review and network meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology 126:5, pages 556-567.
Crossref
Crossref
Cordelia Whitlatch & Erin Morgan. (2019) Is intramuscular progesterone more effective for preterm labor prevention than intravaginal progesterone?. Evidence-Based Practice 22:3, pages 14-14.
Crossref
Crossref
Balaji Govindaswami, Priya Jegatheesan, Matthew Nudelman & Sudha Rani Narasimhan. (2018) Prevention of Prematurity. Clinics in Perinatology 45:3, pages 579-595.
Crossref
Crossref
A Jarde, O Lutsiv, CK Park, J Beyene, JM Dodd, J Barrett, PS Shah, JL Cook, S Saito, AB Biringer, L Sabatino, L Giglia, Z Han, K Staub, W Mundle, J Chamberlain & SD McDonald. (2017) Effectiveness of progesterone, cerclage and pessary for preventing preterm birth in singleton pregnancies: a systematic review and network meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology 124:8, pages 1176-1189.
Crossref
Crossref
G. Saccone, A. Khalifeh, A. Elimian, E. Bahrami, K. Chaman‐Ara, M. A. Bahrami & V. Berghella. (2017)
Vaginal progesterone
vs
intramuscular 17α‐hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta‐analysis of randomized controlled trials
. Ultrasound in Obstetrics & Gynecology 49:3, pages 315-321.
Crossref
Crossref
Vincenzo Berghella & Rupsa C. Boelig. (2016) Always ask why!. American Journal of Obstetrics and Gynecology 214:3, pages 303-305.
Crossref
Crossref
Young Ju Kim. (2016) Progesterone treatment for the prevention of preterm birth. Journal of the Korean Medical Association 59:4, pages 319.
Crossref
Crossref
Hyun-Joo SeolSuk Joo ChoiSoo-young Oh. (2016) Progesterone Treatment for Prevention of Preterm Birth. Perinatology 27:4, pages 205.
Crossref
Crossref